AstraZeneca announced the availability of charitable contributions of up to $15,000 through the Health and Science Innovation Challenge. The AstraZeneca Health & Science Innovation Challenge provides nonprofits with the opportunity to receive funding to address today’s most pressing health challenges by innovating on traditional approaches and preparing the next generation of leaders to be entrepreneurial problem-solvers.
Beginning July 1, 2017 at 9 AM ET, through Monday July 31, 2017 at 5 PM ET, US-based nonprofit organizations can review the program criteria and submit an online application. Eligible programs must present a new approach, tool or technology to help solve a health challenge, or build knowledge and skills in the fields of science, technology, engineering and math among K-12 or undergraduate students.
The Health and Science Innovation Challenge is a component of AstraZeneca and MedImmune’s commitment to making a meaningful difference in the lives of patients and communities. For more information please visit the Sustainability section of our website.
NOTES TO EDITORS
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, please visit www.astrazeneca-us.com and follow us on Twitter @AstraZenecaUS.
Michele Meixell +1 302 885 2677
Alex Engel +1 302 885 2677